ATE551068T1 - TICK CEMENT PROTEIN CONTAINING VACCINE - Google Patents

TICK CEMENT PROTEIN CONTAINING VACCINE

Info

Publication number
ATE551068T1
ATE551068T1 AT01923827T AT01923827T ATE551068T1 AT E551068 T1 ATE551068 T1 AT E551068T1 AT 01923827 T AT01923827 T AT 01923827T AT 01923827 T AT01923827 T AT 01923827T AT E551068 T1 ATE551068 T1 AT E551068T1
Authority
AT
Austria
Prior art keywords
tick cement
protein containing
containing vaccine
cement protein
tick
Prior art date
Application number
AT01923827T
Other languages
German (de)
Inventor
Adama Roseanne Trimnell
Guido Christiaan Paesen
Patricia Anne Nuttall
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Priority claimed from PCT/GB2001/001834 external-priority patent/WO2001080881A1/en
Application granted granted Critical
Publication of ATE551068T1 publication Critical patent/ATE551068T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Insects & Arthropods (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to the use of tick cement proteins in the production of vaccines for protecting animals against the bite of blood-sucking ectoparasites and against the transmission of viruses, bacteria and other pathogens by such ectoparasites. When used as vaccine components, the tick cement proteins of the invention confer broad cross-reactivity against a variety of species of ectoparasite.
AT01923827T 2000-04-25 2001-04-25 TICK CEMENT PROTEIN CONTAINING VACCINE ATE551068T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0010068.5A GB0010068D0 (en) 2000-04-25 2000-04-25 Vaccine composition
GBGB0028606.2A GB0028606D0 (en) 2000-04-25 2000-11-23 Vaccine composition
PCT/GB2001/001834 WO2001080881A1 (en) 2000-04-25 2001-04-25 Vaccine comprising a tick cement protein

Publications (1)

Publication Number Publication Date
ATE551068T1 true ATE551068T1 (en) 2012-04-15

Family

ID=9890483

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01923827T ATE551068T1 (en) 2000-04-25 2001-04-25 TICK CEMENT PROTEIN CONTAINING VACCINE

Country Status (5)

Country Link
JP (1) JP4925236B2 (en)
CN (1) CN101406696A (en)
AT (1) ATE551068T1 (en)
CU (1) CU23358B7 (en)
GB (2) GB0010068D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540583B (en) * 2018-05-29 2022-07-15 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) Sickle rhipicephalus vacuole sortilin molecule and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723945D0 (en) * 1997-11-12 1998-01-07 Nat Environmental Research Cou Tissue cement

Also Published As

Publication number Publication date
CU23358B7 (en) 2009-03-16
GB0010068D0 (en) 2000-06-14
JP4925236B2 (en) 2012-04-25
CN101406696A (en) 2009-04-15
JP2003531177A (en) 2003-10-21
GB0028606D0 (en) 2001-01-10

Similar Documents

Publication Publication Date Title
ATE451119T1 (en) SUBUNITY VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS
WO2004030608A3 (en) Nanoemulsion vaccines
NO20034244L (en) Microbial feed for aquaculture and agriculture
ATE556596T1 (en) REGULATED ATTENUATION OF LIVE VACCINES TO IMPROVE CROSS-IMMMUNITY PROTECTIVE FUNCTION
ATE549032T1 (en) ADJUVANCE COMPOUNDS FOR IMPROVEMENT OF IMMUNE RESPONSES TO POLYNUCLEOTIDE-BASED VACCINES
NO20062044L (en) Piscirickettsia salmonis antigens and their use
DE60226911D1 (en) Development of a vaccine for the prevention of filovirus infections in primates
BR0110278A (en) A vaccine, antibody or antiserum composition, methods of producing an antibody or antiserum and immunizing an animal against a blood-eating ectoparasite, tick cement protein, and use of a protein tick cement
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
NO20062469L (en) Streptococcus phocae vaccine
ATE349520T1 (en) TISSUE CEMENT PROTEINS FROM RHIPICEPHALUS APPENDICULATUS
CY1109206T1 (en) gM- NEGATIVE EHV-MUTALS WITHOUT HARTEROGICAL INFORMATION
ATE551068T1 (en) TICK CEMENT PROTEIN CONTAINING VACCINE
ATE487489T1 (en) RECOMBINANT INTRACELLULAR PATHOGEN IMMUNOGENIC COMPOSITIONS AND METHODS OF USE
ATE476987T1 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDASIS
DE60238554D1 (en) Vaccine against Infectious Diseases
WO2004082596A3 (en) Yersinia species compositions
DK1074266T3 (en) Live attenuated bacteria for use in vaccine
ATE353226T1 (en) ADJUVANT COMPOSITION CONTAINING FHA OR AN FHA FRAGMENT IN FREE FORM
CY1107374T1 (en) FISH VACCINE AGAINST PISCIRICKETTSIA SALMONIS
ATE495757T1 (en) LIVE ATTENUATE BACTERIAL VACCINE
WO2006037383A8 (en) Piscirickettsia salmonis antigens and use thereof
DE60233391D1 (en) VACCINE FOR THE PROTECTION OF ANIMALS AGAINST LEISHMANIA
WO2004019883A3 (en) Tick polypeptides as anticoagulants and vaccines
TH95334A (en) The use of vaccines for the treatment / prevention of the transmission of pathogens.